Viewing Study NCT05433532

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2026-04-04 @ 7:58 AM
Study NCT ID: NCT05433532
Status: COMPLETED
Last Update Posted: 2024-04-25
First Post: 2022-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients
Sponsor: The First Affiliated Hospital of Soochow University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Philadelphia Chromosome View
None Acute Myeloid Leukemia View
None Acute Lymphoblastic Leukemia View
None Chronic Myeloid Leukemia View
None Mixed Phenotype Acute Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ph-positive AL View
None CML-AP/BP View
None Azacitidine+Venetoclax+Flumatinib View